Nursing Intervention of Negative Emotion in Patients with Viral Hepatitis Treated with Interferon

Yue Liu, Feng Min, Jianyun Xu

Abstract


Objective: To evaluate the effect of nursing intervention on negative emotion of patients with viral hepatitis treated with interferon. Methods: 72 patients with viral hepatitis in our hospital from May 2020 to May 2021 were selected and divided into the control group and the observation group according to the coin method, 36 cases/group, providing routine intervention for the control group and nursing intervention for the observation group. Results: The incidence of adverse reactions (Weight loss rate, leucopenia rate, thrombocytopenia rate and hair loss rate) in the observation group (5.56%) was lower than that in the control group (27.78%), (P < 0.05) with statistical significance. The SAS anxiety score (32.63 ± 3.25) and SDS depression score (31.25 ± 4.23) of the observation group were lower than those of the control group (41.15 ± 4.89) and (40.13 ± 4.89), and the PSQI sleep quality score of the observation group (5.01 ± 0.36) was lower than that of the control group (9.89 ± 1.25), (P < 0.05) with statistical significance. The treatment compliance of the observation group (100.00%) was higher than that of the control group (83.33%), (P < 0.05) with statistical significance. Conclusions: The application of nursing intervention in the treatment of viral hepatitis patients with interferon can significantly improve the negative emotions of patients, which is worthy of promotion.

Keywords


Viral hepatitis; Interferon; Negative emotion; Nursing intervention

References


LI Li-hong, CAI Ling-zhi, LIU Xue-feng, et al. Side effects and

intervention of interferon in the treatment of chronic viral hepatitis

[J]. Chinese Journal of nosocomial infection, 2020,30 (12): 1845-

LIU Yuan-yuan.Effect of entecavir combined with interferon α-2α

on HBV-DNA negative conversion in patients with viral hepatitis

B [J]. Systems medicine, 2020,5 (1): 16-18.

LIU Ze-lin. Effect of entecavir combined with pegylated interferon

α-2a on HBV-DNA negative and serum YKL-40 and CEA levels in

patients with viral hepatitis B [J]. Maternal infant world, 2020 (27):

MIAO Xiao-li. Adverse reactions of pegylated interferon α-2α(pegylated

interferon) in the treatment of chronic hepatitis C [J]. Drug

evaluation, 2020,17 (3): 12-13,15.

ZHANG Chen, SHANG Li. Adefovir dipivoxil combined with

recombinant human interferon α2b injection in the treatment of

patients with viral hepatitis B [J]. Clinical medical research and

practice, 2020,5 (5): 46-48.

GUO Yan. Clinical efficacy and safety of entecavir combined with

pegylated interferon α-2a in the treatment of chronic hepatitis B [J].

Northern pharmacy, 2019,16 (1): 170-171.

TANG Mao-gang, Tang Jing-shan . Tenofovir and entecavir for the

treatment of hepatitis B virus positive chronic hepatitis with ineffective

interferon [J]. Heilongjiang medicine, 2020,44 (12): 1709-




DOI: https://doi.org/10.12346/jnp.v1i1.4255

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Yue Liu, Feng Min, Jianyun Xu

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.